Retrospective analysis of 65 Chinese children with acute promyelocyte leukemia: A single center experience

Pediatric Blood and Cancer

Volumn 51, Issue 2, 2008, Pages 210-215

  Zhang, Li ^a   Zhao, Hui ^a   Zhu, Xiaofan ^a   Chen, Yumei ^a   Zou, Yao ^a   Chen, Xiaojuan ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Acute promyelocytic leukemia; AS2O3; ATRA; Children

Indexed keywords

ARSENIC TRIOXIDE; CYTARABINE; DAUNORUBICIN; HOMOHARRINGTONINE; HYDROXYUREA; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISONE; RETINOIC ACID; ANTINEOPLASTIC AGENT; ORGANOARSENIC DERIVATIVE; OXIDE;

ADOLESCENT; ARTICLE; BONE PAIN; CANCER PATIENT; CARDIOTOXICITY; CHILD; CHILDHOOD LEUKEMIA; DEATH; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY SKIN; FEMALE; FEVER; FOOT EDEMA; HEADACHE; HUMAN; LEUKEMIA RELAPSE; LEUKOCYTOSIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MUCOSAL DRYNESS; MYALGIA; NAUSEA; NEPHROTOXICITY; PATIENT IDENTIFICATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RETROSPECTIVE STUDY; SIDE EFFECT; SUDDEN DEATH; TREATMENT OUTCOME; INFANT; PRESCHOOL CHILD; PROGNOSIS; RECURRENT DISEASE;

ADOLESCENT; ANTINEOPLASTIC AGENTS; ARSENICALS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; OXIDES; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRETINOIN;

EID: 45549091070     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21510     Document Type: Article

References (19)

1. Guglielmi C, Martelli MP, Diverio D, et al. Immunophenotype of adult and childhood acute promyelocytic leukemia: Correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. Br J Haematol 1998;102:1035-1041.
2. Testi AM, Biondi A, Lo Coco F, et al. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood 2005;106:447-453.
3. Ortega JJ, Madero L, Martin G, et al. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: A multicenter study by the PETHEMA Group. J Clin Oncol 2005;23:7632-7640.
4. de Botton S, Coiteux V, Chevret S, et al. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol 2004;22:1012-1404.
5. Mann G, Reinhardt D, Ritter J, et al. Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children. Ann Hematol 2001;80:417-422.
6. Gregory J, Jr., Feusner J. Acute promyelocytic leukaemia in children. Best Pract Res Clin Haematol 2003;16:483-494.
7. Lo Coco F, Diverio D, Falini B, et al. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. Blood 1999;94:12-22.
8. Soignet SL, Frankel SR, Douer D, et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 2001;19:3852-3860.
9. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997;89:3354-3360.
10. Mathews V, Balasubramanian P, Shaji RV, et al. Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: A single center experience. Am J Hematol 2002;70:292-299.
11. George B, Mathews V, Poonkuzhali B, et al. Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: A single center experience. Leukemia 2004;18:1587-1590.
12. Mathews V, George B, Lakshmi KM, et al. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: Durable remissions with minimal toxicity. Blood 2006;107:2627-2632.
13. Avvisati G, Lo Coco F, Diverio D, et al. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: A Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study. Blood 1996;88:1390-1398.
14. Frankel SR, Eardley A, Lauwers G, et al. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med 1992;117:292-296.
15. Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003;21:4642-4649.
16. Kell WJ, Burnett AK, Chopra R, et al. A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia. Blood 2003;102:4277-4283.
17. Schoch C, Haase D, Haferlach T, et al. Incidence and implication of additional chromosome aberrations in acute promyelocytic leukaemia with translocation t(15;17)(q22;q21): A report on 50 patients. Br J Haematol 1996;94:493-500.
18. Sanz MA, Lo Coco F, Martin G, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups. Blood 2000;96:1247-1253.
19. Gregory J, Jr., Feusner J. Acute promyelocytic leukaemia in children. Best Pract Res Clin Haematol 2003;16:483-494.